Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00726388 · ClinicalTrials.gov registry record · Phase 3
An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,050
- Enrollment target
NCT00726388 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 1,050 participants.
The verdict
NCT00726388, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,050 participants
- Enrollment target
Study Summary
This is an open-label, multiple-dose, safety study of DIC075V in patients with acute post-operative pain following abdominal or orthopedic surgery.
Interventions
- DRUG DIC075V (intravenous diclofenac sodium)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,050 participants |
| Start Date | 2008-09-15 |
| Est. Completion | 2009-05-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00726388
The ClinicalTrials.gov registry entry for NCT00726388 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,050 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DIC075V (intravenous diclofenac sodium) is the first listed.
NCT00726388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00726388 about?
NCT00726388 is a clinical study titled "An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain". This is an open-label, multiple-dose, safety study of DIC075V in patients with acute post-operative pain following abdominal or orthopedic surgery.
What is the current status of trial NCT00726388?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,050 participants. The study started on 2008-09-15. Estimated completion is 2009-05-08.
What interventions are being tested in trial NCT00726388?
The interventions under investigation include: DIC075V (intravenous diclofenac sodium) (DRUG).
Who is sponsoring clinical trial NCT00726388?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.